YorkBridge Wealth Partners’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
YorkBridge Wealth Partners's KITE Position: Q4 2017 in Review
YorkBridge Wealth Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 100 shares — an estimated $18K sold.
YorkBridge Wealth Partners first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $18K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- YorkBridge Wealth Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- YorkBridge Wealth Partners sold 100 Kite Pharma, Inc. shares in Q4 2017, an estimated $18K.
- YorkBridge Wealth Partners first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
- YorkBridge Wealth Partners's Kite Pharma, Inc. position peaked at $18K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on YorkBridge Wealth Partners's 13F filing for Q4 2017, filed 12 Feb 2018.